Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 104

Sort by

Sort Order Select

Journal Articles

Lactylation-related LGALS1 promotes immunosuppressive tumor microenvironment and venetoclax resistance in Acute Myeloid Leukemia

Bobin Su, Yan Zhang, Changqing Jiao, Junjie Zhou, Enbo Chen, Jian Ge

Blood (2025) 146 (Supplement 1): 5009.

https://doi.org/10.1182/blood-2025-5009

Published: 2025

Journal Articles

Hypoxia-driven complement activation expands circulating endothelial cells in transplant-associated thrombotic microangiopathy: A multi-omics single-cell and functional study

Jiaqian Qi, Yan Zhang, Lijun Zhou, Liangliang Wang, Shuhui Jiang, Xin Ye, Guocai Mao, Xuedong Wei, Yuhuang Huang, Linkun Hu, Han Yue, Hao Jiang

Blood (2025) 146 (Supplement 1): 199.

https://doi.org/10.1182/blood-2025-199

Published: 2025

Journal Articles

Pola-R-CHP in previously untreated low-risk (IPI 0-1) DLBCL: A nationwide multicenter retrospective study in China

Blood (2025) 146 (Supplement 1): 7229.

https://doi.org/10.1182/blood-2025-7229

Published: 2025

Journal Articles

Mitochondria contribute to naip/NLRC4 inflammasome assembly and activation in macrophage

Ling Yang, Yan Zhang, Zhuodong Chai, Yuqi Zhou, Cui Jian, Guoying Zhang, Yinan Wei, Zhenyu Li

Blood (2025) 146 (Supplement 1): 2983.

https://doi.org/10.1182/blood-2025-2983

Published: 2025

Journal Articles

Golidocitinib combined with CHOP in newly-diagnosed peripheral T-cell lymphoma: Preliminary Results from A phase 1/2 clinical trial

Chong Wei, Wei Zhang, Dao-Bin Zhou, Jian Li, Yan Zhang, Kaini Shen, Wei Wang, Zi Wang, Danqing Zhao, Jing Ruan, Huacong Cai, Yueying Mao

Blood (2025) 146 (Supplement 1): 6322.

https://doi.org/10.1182/blood-2025-6322

Published: 2025

Journal Articles

PTP4A3: A potential therapeutic target in Acute Myeloid Leukemia

Changqing Jiao, Junjie Zhou, Yan Zhang, Enbo Chen, Mengya Pan, Jian Ge

Blood (2025) 146 (Supplement 1): 1460.

https://doi.org/10.1182/blood-2025-1460

Published: 2025

Journal Articles

Genetic analysis and clinical correlations in marginal zone lymphoma

Wei Wang, Hao Cai, Yan Zhang, Jian Li

Blood (2025) 146 (Supplement 1): 1768.

https://doi.org/10.1182/blood-2025-1768

Published: 2025

Journal Articles

BNP promotes platelet activation and thrombosis via its receptor natriureticpeptide receptor-a (NPRA): A paradigm shift from biomarker to effector

Yan Zhang, Zhenyu Li, Fadi Khasawneh, Fatima Alshbool

Blood (2025) 146 (Supplement 1): 419.

https://doi.org/10.1182/blood-2025-419

Published: 2025

Journal Articles

Efficacy and safety of orelabrutinib, obinutuzumab, and lenalidomide in previously untreated marginal zone lymphoma: Preliminary results from a prospective, single-arm, multicenter, Phase II study

Wei Wang, Yueying Mao, Jing Ruan, Huacong Cai, Jin Ye, JunLi Chen, Liang Wang, Wenrong Huang, Yan Zhang, Jian Li

Blood (2025) 146 (Supplement 1): 5383.

https://doi.org/10.1182/blood-2025-5383

Published: 2025

Journal Articles

First-in-human phase I study of HCB101, a 3.5th-generation CD47-SIRPα fc fusion protein: Cytopenia-sparing safety, broad pharmacologic window, and low-dose clinical activity in relapsed/refractory non-Hodgkin lymphoma

Abigail Yu, Wenyu Li, Zhili Zhou, Junjie Li, Charles Wang, Wei Ji, Ying Wang, Jian Zhang, Wei-Hong Cheng, Tian Zhang, Chihyi Hsieh, Alvin Luk, Vivien Zhang, David Sun, Yan Zhang

Blood (2025) 146 (Supplement 1): 3299.

https://doi.org/10.1182/blood-2025-3299

Published: 2025

Journal Articles

MBS314, a GPRC5DxBCMAxCD3 trispecific antibody, in relapsed/refractory multiple myeloma (RRMM): Updated results from a Phase 1 dose escalation study

Gang An, Wenming Chen, Wen Gao, Ting Yang, Lijie Xing, Kaihong Xu, Yan Zhang, Tong Xu, Min Wei, Feng Li, Guojin Wu, Jinying Ning, Lugui Qiu

Blood (2025) 146 (Supplement 1): 2274.

https://doi.org/10.1182/blood-2025-2274

Published: 2025

Journal Articles

Proof-of-concept study of the CD39-blocking antibody JS019 in eosinophilic-associated disorders

Danqing Zhao, Huishan Sun, Jian Li, Hanping Wang, Yan Zhang

Blood (2025) 146 (Supplement 1): 189.

https://doi.org/10.1182/blood-2025-189

Published: 2025

Journal Articles

Conversion from calcineurin inhibitor to ruxolitinib as GVHD prophylaxis during patients with transplant-associated thrombotic microangiopathy

Yan Zhang, Hanyin Liang, Na Xu

Blood (2025) 146 (Supplement 1): 7718.

https://doi.org/10.1182/blood-2025-7718

Published: 2025

Journal Articles

Chemotherapy-free induction with pomalidomide, orelabrutinib, and rituximab (POR) followed by high-dose methotrexate,rituximab and orelabrutinin (ROM) in newly diagnosed primary CNS lymphoma: Interim analysis of a phase II study

Yan Zhang, Huiying Zhu, Zhangyuting He, Danqing Zhao, Chong Wei, Jing Ruan, Jian Li, Wei Zhang, Dao-Bin Zhou

Blood (2025) 146 (Supplement 1): 5471.

https://doi.org/10.1182/blood-2025-5471

Published: 2025

Journal Articles

Exploration of optimal high-dose methotrexate-based therapy for patients with primary CNS lymphoma: A real-world study in China

Huiying Zhu, Zhangyuting He, Chong Wei, Jing Ruan, Danqing Zhao, Wei Zhang, Jian Li, Dao-Bin Zhou, Yan Zhang

Blood (2025) 146 (Supplement 1): 3693.

https://doi.org/10.1182/blood-2025-3693

Published: 2025

Journal Articles

Exploring the multi-target pharmacology of ginseng against Acute Myeloid Leukemia by integrating single-cell sequencing, molecular docking, and network pharmacology

Yan Zhang, Bobin Su, Changqing Jiao, Junjie Zhou, Enbo Chen, Jian Ge

Blood (2025) 146 (Supplement 1): 6773.

https://doi.org/10.1182/blood-2025-6773

Published: 2025

Journal Articles

Therapeutic targeting of the recurrent mutant TP53R248Q neoantigen by T cell receptor-engineered T cells in human cancers

Blood (2025) 146 (Supplement 1): 4135.

https://doi.org/10.1182/blood-2025-4135

Published: 2025

Journal Articles

Rapid, efficient and durable fetal hemoglobin production following CS-101 treatment in transfusion-dependent β-thalassemia participants: An autologous, ex vivo edited CD34+ stem cell product using the innovative transformer base editor (tBE)

Jia Chen, Yongrong Lai, Xiaowen Zhai, Wei Li Zhao, Rongrong Liu, Xiaowen Qian, Wei Tang, Lijie Wang, Xu-Kai Ma, Yaliang Li, Jia Wei, Kewei Lan, Yan Zhang, Li Yang, Xiaodun (Susan) Mou

Blood (2025) 146 (Supplement 1): 6090.

https://doi.org/10.1182/blood-2025-6090

Published: 2025

Journal Articles

IFN-γ-induced CD4+ CADM1+ T cells emerged as malignancy-progressive biomarkers in EBV NK/T lymphoproliferative disorders and potential drivers of malignant expansion in AITL

Jian Li, Yan Zhang, Qinhuan Luo, Dao-Bin Zhou, Yiao Di, Wei Zhang, Chong Wei

Blood (2025) 146 (Supplement 1): 3530.

https://doi.org/10.1182/blood-2025-3530

Published: 2025

Journal Articles

A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

Blood (2025) 145 (14): 1526–1535.

https://doi.org/10.1182/blood.2024026401

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Lactylation-related LGALS1 promotes immunosuppressive tumor microenvironment and venetoclax resistance in Acute Myeloid Leukemia

Hypoxia-driven complement activation expands circulating endothelial cells in transplant-associated thrombotic microangiopathy: A multi-omics single-cell and functional study

Pola-R-CHP in previously untreated low-risk (IPI 0-1) DLBCL: A nationwide multicenter retrospective study in China

Mitochondria contribute to naip/NLRC4 inflammasome assembly and activation in macrophage

Golidocitinib combined with CHOP in newly-diagnosed peripheral T-cell lymphoma: Preliminary Results from A phase 1/2 clinical trial

PTP4A3: A potential therapeutic target in Acute Myeloid Leukemia

Genetic analysis and clinical correlations in marginal zone lymphoma

BNP promotes platelet activation and thrombosis via its receptor natriureticpeptide receptor-a (NPRA): A paradigm shift from biomarker to effector

Efficacy and safety of orelabrutinib, obinutuzumab, and lenalidomide in previously untreated marginal zone lymphoma: Preliminary results from a prospective, single-arm, multicenter, Phase II study

First-in-human phase I study of HCB101, a 3.5th-generation CD47-SIRPα fc fusion protein: Cytopenia-sparing safety, broad pharmacologic window, and low-dose clinical activity in relapsed/refractory non-Hodgkin lymphoma

MBS314, a GPRC5DxBCMAxCD3 trispecific antibody, in relapsed/refractory multiple myeloma (RRMM): Updated results from a Phase 1 dose escalation study

Proof-of-concept study of the CD39-blocking antibody JS019 in eosinophilic-associated disorders

Conversion from calcineurin inhibitor to ruxolitinib as GVHD prophylaxis during patients with transplant-associated thrombotic microangiopathy

Chemotherapy-free induction with pomalidomide, orelabrutinib, and rituximab (POR) followed by high-dose methotrexate,rituximab and orelabrutinin (ROM) in newly diagnosed primary CNS lymphoma: Interim analysis of a phase II study

Exploration of optimal high-dose methotrexate-based therapy for patients with primary CNS lymphoma: A real-world study in China

Exploring the multi-target pharmacology of ginseng against Acute Myeloid Leukemia by integrating single-cell sequencing, molecular docking, and network pharmacology

Therapeutic targeting of the recurrent mutant TP53R248Q neoantigen by T cell receptor-engineered T cells in human cancers

Rapid, efficient and durable fetal hemoglobin production following CS-101 treatment in transfusion-dependent β-thalassemia participants: An autologous, ex vivo edited CD34+ stem cell product using the innovative transformer base editor (tBE)

IFN-γ-induced CD4+ CADM1+ T cells emerged as malignancy-progressive biomarkers in EBV NK/T lymphoproliferative disorders and potential drivers of malignant expansion in AITL

A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only